Lecia Sequist, MD, MPH and Dr. Cardinale Smith addressing key lung cancer disparities in Black patients. We need to turn understanding into action. At the Mass General Cancer Center 3rd Annual Cancer Equity Colloquium.

A major worldwide software outage has affected many of our systems at Mass General Hospital, as well as many major businesses across the country. Due to the severity of this issue, all previously scheduled non-urgent surgeries, procedures, and medical visits are cancelled today.

An actual hero. This is what America First looks like when it’s a lived ethos, rather than a mask for narcissism and ambition.

All I have to say is let's not fuck this up, fellow white women

The framers of our Constitution knew that our republic would endure only if our presidents have the character and honor to put duty ahead of self interest. President Biden deserves our gratitude for his decades of service to our nation and for his courageous decision today.

Longitudinal ctDNA Analysis on Osimertinib in FLAURA&AURA3 trials: - ctDNA PD preceded RECIST by 2.6-3.4m Interesting, but the APPLE trial Jordi Remon asks the key quesn- does tx switch at ctDNA PD impact survival? Answer: No JTO & JTO CRR OncoAlert #LCSM jto.org/article/S1556-…

Dr. Kazerooni Ella Kazerooni 〽️ gave a terrific talk discussing #screening uptake & adherence in the U.S. Up-to-date prevalence of #lungcancer screening is 18.1% with state variation ranging 9.7%-31%! Still a lot of work to do-our team feeling incredibly inspired to get the rate to 100%!!

“Lung cancer is not a science problem. It is a political problem.” - Ray Osarogiagbon Raymond Osarogiagbon, MBBS, FACP 🔥 🔥 🔥 #WCLC24 IASLC #lcsm #lungcancerscreening #earlydetection

Superstar! 👏👏👏

HUGE congratulations to ALCSI's very own Alexandra Potter Alexandra Potter & Chinmay Haridas Chinmay Haridas for receiving the IASLC #WCLC24 Early Career Education Award & International Mentorship Program Award!! We are so proud of you!! Both of them have presentations at WCLC!!

Amazing discussion by Lecia Sequist, MD, MPH & Heather Wakelee on challenges of deciding when to 🛑immunotherapy for metastatic NSCLC, reviewing data favoring stopping IO at 2 yrs, but acknowledging progression in half of pts, & with half of those pts responding to re-challenge #WCLC2024

Great talk from Raymond Osarogiagbon, MBBS, FACP about disparities and health equity in lung cancer screening. One key takeaway is that too much research identifies population experiencing disparities and the magnitude and stops there. Must push to intervention and policy is a good start #WCLC24

Here to support Zosia Piotrowska MGH Thoracic Oncology giving a clear and concise overview of 1L therapies for patients with EGFR+ #lungcancer in 🇺🇸 🙏🙏🙏 #wclc24 Lecia Sequist, MD, MPH Allison Chang

Great session on #targetedtherapies, w/ brilliant discussion by JessicaJLinMD! 💠Interesting STARLET pooled RCT analysis of osi w/ or w/o SRS for🧠mets➡️no significant🧠PFS benefit with upfront SRS 💠QOL data from KRYSTAL12 & PALOMA3, showing🔑role of #PROs in trials #WCLC24

Dr. Mike Gieske Michael Gieske, M.D. gave a phenomenal talk the #lungcancer screening program St. Elizabeth. A testament to the program's dedicated nodule management team and nurse navigators, there has been an incredible shift towards earlier stages of disease diagnosis!! So impressive!!

Really exciting to watch Erica Warner, ScD present the initial results from the MGH FireHealthStudy.org at #wclc24 👏🏽 Stay tuned to hear more soon! Also, we are looking for firefighters diagnosed with lung cancer to enroll - please refer such people to our website 💕

So grateful to work with this brilliant and compassionate group, and excited for all we’ll accomplish in the coming years! 🎉 🙏

Congratulations Jeff Yang MD FACS on your well deserved recognition by IASLC w the Cliff Mountain staging award. Your lecture meaningfully demonstrated how staging is a language we share w each other, with patients and with the public. You and ALCSI are inspiring a generation!